Antisense Oligonucleotides (ASOs): RNA-Based Precision in Retinitis Pigmentosa Treatment
RNA-based therapies, specifically Antisense Oligonucleotides (ASOs), are emerging as a powerful and highly precise class of molecules for treating certain genetic forms of Retinitis Pigmentosa (RP). ASOs are short, synthetic chains of nucleic acids designed to bind to a specific sequence of the patient's messenger RNA (mRNA). By binding to this target RNA, the ASO can modify how the genetic...
0 التعليقات 0 المشاركات 239 مشاهدة 0 معاينة
MTSocial https://mtsocial.ir